CSP Technologies, Inc. develops Pharmapuck scavenging devices, an integrated solution for oral solid dose products

  • Aptar CSP Technologies

CSP Technologies, Inc. – a leader in packaging solutions that ensure product protection, enhance brand recognition and improve consumer experiences – has introduced a new active scavenging solution that can be integrated directly into primary containers to protect oral solid dose (OSD) products from moisture and oxygen absorption.  Suitable for nearly any typical OSD container, Pharmapuck™ scavenging devices can be integrated into bottle tops or dropped into containers to counteract the introduction of volatile organic compounds in packaging headspace – an occurrence that can lead to displeasing odors or even reduced efficacy or shelf-life.

The Pharmapuck™ scavenging device has the potential to set a new industry standard by providing pharmaceutical manufacturers a foolproof solution to protect their products and prevent misuse by consumers.  Its molded-in desiccant eliminates the risk of breakage or spillage associated with sachets and canisters. Pharmapuck™ scavenging devices also provide added design flexibility and branding options such as custom coloring, and laser or ink printing to enhance customer awareness and safety. Finally, Pharmapuck™ scavenging devices are available in ultra-low particulate formats for high-sensitivity drug applications.

Key benefits of CSP Technologies, Inc.’s new Pharmapuck™ integrated scavenging solution include:

  • Durability: Enhanced cleaning and sterilization capabilities, to perform in the most demanding environments required of pharmaceutical packaging
  • Product stability: Molded-in desiccant eliminates risk of desiccant breakage or spillage associated with sachets and canisters
  • Consistent customer experience: Controls odors and release of aromas
  • Design flexibility: Ability to be integrated into virtually any container
  • Visual branding options: Custom coloring, laser or ink printing for enhanced consumer awareness and safety

For over 30 years, CSP Technologies, Inc. has been a leader in delivering desiccant and other gas scavenging solutions to enhance product stability, extend shelf life and enable new packaging options for pharmaceutical manufacturers. The company’s Activ-Film™ materials, Activ-Blister™ solutions, and Activ-Polymer™ technologies are used by leading manufacturers to protect products against moisture, oxygen, VOC’s, and odors in highly sensitive environments, allowing for significant shelf life extension.

See also

Aptar CSP Technologies’ Activ-Blister™ Solutions Now Available for Manufacturing in the EMEA Region

Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science solutions to ensure product protection, extend shelf life and improve patient experience, announces a new manufacturing site able to produce its Activ-Blister™ Solutions for oral slide dose drugs in Europe. The move is part of a key strategic effort to expand production of Activ-Blister™ technology globally.

Aptar CSP presents 'rethinking oral solid dose packaging' webinar

Aptar CSP Technologies – a leader in active packaging solutions that ensure product protection, enhance brand recognition and improve use experiences, and part of AptarGroup Inc – is presenting its Activ-Blister Solutions for the protection of moisture and oxygen-sensitive tablets and capsules, alongside FreeThink Technologies and its ASAPprime technology for accelerated shelf-life determination. The combination is a “right the first time” approach to stability challenges and blister package design that virtually eliminates protracted testing and costly reformulations.

CSP Technologies' focus for enhancing the shelf life for transdermal and oral solid dose drugs

Despite being two very different drug delivery platforms, oral solid doses and transdermal patches can face similar packaging headspace challenges that impact shelf life; besides moisture and oxygen ingress, exposure to certain conditions can lead to the formation of volatile organic compounds (VOCs) and other gases that, in turn, may interact with drug products and capsules, adversely impacting their stability.

  • Elias Bittan
  • Product Info
  • English
  • Created 29 Sep 2016
  • Modified 04 Sep 2019
  • Hits 1333